Partner Content Partner Content Agenda Released for 3D Cell Culture 2018 Agenda Released for 3D Cell Culture 2018
Events Partner Content CRISPR & Precision Gene Editing Congress - Berlin 2017 CRISPR & Precision Gene Editing Congress Berlin 2017
News CRISPR Therapeutics plans Nasdaq launch CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering.
News China to begin first in-human CRISPR trial next month Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
